Key facts
- Kitea Health’s last known valuation is $18.4M (Feb 2023).
- It has raised $27.5M; the latest was Early Stage VC ($13.0M) in Dec 2025.
- Notable investors include MedTech Innovator, Icehouse Ventures, New Zealand Growth Capital Partners, Aspire NZ Seed Fund, Auckland UniServices — 18 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 18 names
- ·Watchlist + deal alerts for Kitea Health
- ·The full record, as it builds
Funding rounds
No funding rounds for Kitea Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Kitea Health
Operator of a medical technology company intended to develop micro-implantable devices for proactive chronic health management. The company aims to offer an implantable device integrated with software that can receive power and send data to a communication rod through flesh and bone to manage hydrocephalus, enabling healthcare organizations to monitor intracranial and cardiac pressure remotely and support early clinical intervention.
- Sector
- Healthcare
- HQ
- Auckland, New Zealand
- Founded
- 2021
- Employees
- 24
- Website
- kiteahealth.com/
- Ownership
- Privately Held (backing)
Kitea Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Kitea Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Kitea Health in its N-PORT filings yet. We sweep new filings monthly.